NYSE · Healthcare
Warby Parker Inc. (WRBY)
As-reported financials and recent SEC filings for Warby Parker Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$871.9M
Net income
$1.6M
Net margin
0.2%
Diluted EPS
$0.01
ROE
0.4%
P/E (TTM)
2924.0×
Market cap
$3.59B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $871.9M | $771.3M | $669.8M | $598.1M | $540.8M |
| Gross profit | $470.6M | $426.8M | $365.2M | $341.1M | $317.7M |
| Operating income | $-5.3M | $-30.1M | $-72.0M | $-111.2M | $-143.7M |
| Net income | $1.6M | $-20.4M | $-63.2M | $-110.4M | $-144.3M |
| Diluted EPS | $0.01 | $-0.17 | $-0.54 | $-0.96 | $-2.21 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-23
View on EDGAR →42026-06-18
View on EDGAR →1442026-06-16
View on EDGAR →1442026-06-12
View on EDGAR →8-K2026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →Go deeper on WRBY
Search Warby Parker Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.